Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes | Zendy

Aldona L. Baltch | Zendy; Lawrence H. Bopp | Zendy; Raymond P. Smith | Zendy; Poul Michelsen | Zendy; William J. Ritz | Zendy

Open Access

Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes

Author(s) -

Aldona L. Baltch,

Lawrence H. Bopp,

Raymond P. Smith,

Poul Michelsen,

William J. Ritz

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki186

Subject(s) - gemifloxacin , moxifloxacin , microbiology and biotechnology , legionella pneumophila , gatifloxacin , levofloxacin , legionella , erythromycin , antibacterial agent , sparfloxacin , ofloxacin , streptococcus pneumoniae , chemistry , antibiotics , biology , bacteria , ciprofloxacin , genetics

The antibacterial activity of a new fluoroquinolone, gemifloxacin, was tested against intracellular Legionella pneumophila and Legionella micdadei and was compared with the activities of levofloxacin, gatifloxacin, moxifloxacin and erythromycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research